Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1674 of 1674 entries
View as:

Feasibility of Exercise and Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT03941600 Org: User:
Start: 04/10/19 End: 08/30/21 Due: 08/30/22

Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1

Phase: N/A Priority: Normal
NCT ID: NCT06129838 Org: User:
Start: 05/05/23 End: 05/31/27 Due: 05/31/28

The Natural History of Asymptomatic Rotator Cuff Tears

Phase: N/A Priority: Normal
NCT ID: NCT00923858 Org: User:
Start: 07/01/05 End: 06/30/22 Due: 06/30/23

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02715609 Org: User:
Start: 06/15/16 End: 05/12/24 Due: 05/12/25

Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell

Phase: N/A Priority: Normal
NCT ID: NCT04710394 Org: User:
Start: 01/11/21 End: 03/11/22 Due: 03/11/23

Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00334321 Org: User:
Start: 04/30/06 End: 09/30/15 Due: 09/30/16

Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

Phase: N/A Priority: Normal
NCT ID: NCT05731440 Org: User:
Start: 11/18/22 End: 12/31/26 Due: 12/31/27

Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

Phase: N/A Priority: Normal
NCT ID: NCT04685798 Org: User:
Start: 09/02/20 End: 09/26/23 Due: 09/26/24

Omega-3 for Depression and Other Cardiac Risk Factors - 2

Phase: N/A Priority: Normal
NCT ID: NCT02021669 Org: User:
Start: 05/14/14 End: 09/13/18 Due: 09/13/19

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

Phase: N/A Priority: Normal
NCT ID: NCT00802815 Org: User:
Start: 04/30/05 End: 05/31/14 Due: 05/31/15

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Phase: N/A Priority: Normal
NCT ID: NCT06040320 Org: User:
Start: 10/04/23 End: 05/31/31 Due: 05/31/32

Vigabatrin and Insulin Sensitivity

Phase: N/A Priority: Normal
NCT ID: NCT04321395 Org: User:
Start: 08/23/21 End: 05/15/24 Due: 05/15/25

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT02573493 Org: User:
Start: 04/13/16 End: 07/01/24 Due: 07/01/25

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT06687772 Org: User:
Start: 01/16/25 End: 07/31/29 Due: 07/31/30

Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia

Phase: N/A Priority: Normal
NCT ID: NCT02919618 Org: User:
Start: 07/31/16 End: 01/01/24 Due: 01/01/25

A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation

Phase: N/A Priority: Normal
NCT ID: NCT02769676 Org: User:
Start: 05/31/16 End: 05/31/18 Due: 05/31/19

Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03199040 Org: User:
Start: 07/23/19 End: 05/01/23 Due: 05/01/24

Toward an Automated Method of Abdominal Fat Segmentation of MR Images

Phase: N/A Priority: Normal
NCT ID: NCT01228968 Org: User:
Start: 10/31/10 End: 02/28/11 Due: 02/28/12

Myocardial Perfusion Imaging Galmydar Rest/Stress

Phase: N/A Priority: Normal
NCT ID: NCT05625490 Org: User:
Start: 11/11/22 End: 04/01/25 Due: 04/01/26

Examining the Role of Pain in the Link Between Early Childhood Adversity and Psychopathology

Phase: N/A Priority: Normal
NCT ID: NCT06445712 Org: User:
Start: 05/01/24 End: 04/30/25 Due: 04/30/26

Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03030261 Org: User:
Start: 11/22/17 End: 09/26/27 Due: 09/26/28

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04331067 Org: User:
Start: 11/19/20 End: 05/31/26 Due: 05/31/27

The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead

Phase: N/A Priority: Normal
NCT ID: NCT01259024 Org: User:
Start: 12/31/11 End: 04/30/12 Due: 04/30/13

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

Phase: N/A Priority: Normal
NCT ID: NCT00823303 Org: User:
Start: 02/28/09 End: 09/30/13 Due: 09/30/14